基本信息
浏览量:83
职业迁徙
个人简介
He is a member of the United States Pharmacopeia (USP). Dr. Mandal has been elected as Fellow of the American Association of Pharmaceutical Scientists (AAPS). He has been recognized for his outstanding contributions in the area of novel and innovative drug delivery.
Our research focuses on the design and development of commercially viable formulations to improve the safety, efficacy, and patient compliance. Cutting-edge research in our laboratory has resulted in controlled release formulations of many therapeutic agents. The microencapsulation techniques developed in our lab have resulted in effective control release formulations for large and small molecules with varying water solubility. One of our formulations has successfully completed Phase I human clinical trial. We have published close to 200 original research papers, reviews, abstracts, and monographs and filed five patents.
Our research focuses on the design and development of commercially viable formulations to improve the safety, efficacy, and patient compliance. Cutting-edge research in our laboratory has resulted in controlled release formulations of many therapeutic agents. The microencapsulation techniques developed in our lab have resulted in effective control release formulations for large and small molecules with varying water solubility. One of our formulations has successfully completed Phase I human clinical trial. We have published close to 200 original research papers, reviews, abstracts, and monographs and filed five patents.
研究兴趣
论文共 229 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
JOURNAL OF POLYMER SCIENCEno. 6 (2024): 1074-1114
MACROMOLECULESno. 4 (2024): 1699-1712
Catalysis Science & Technologyno. 9 (2024): 2503-2513
CATALYSIS SCIENCE & TECHNOLOGY (2024)
Langmuir : the ACS journal of surfaces and colloidsno. 28 (2023): 9757-9772
引用1浏览0WOS引用
1
0
European Polymer Journal (2023): 112469-112469
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn